Log in to save to my catalogue

Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (...

Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ae4e6bbe94f84e25ae0ae7ebb9f5218a

Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version)

About this item

Full title

Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version)

Publisher

Japan: John Wiley & Sons, Inc

Journal title

Journal of diabetes investigation, 2025-01, Vol.16 (1), p.163-168

Language

English

Formats

Publication information

Publisher

Japan: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Insulin treatment should be introduced in patients with slowly progressive type 1 diabetes (SPIDDM; definite), according to the revised diagnostic criteria of SPIDDM (2023). In contrast, SPIDDM (probable) patients are in a non‐insulin‐dependent state; therefore, a more flexible treatment can be considered, although sulfonylurea agents should be avo...

Alternative Titles

Full title

Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ae4e6bbe94f84e25ae0ae7ebb9f5218a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ae4e6bbe94f84e25ae0ae7ebb9f5218a

Other Identifiers

ISSN

2040-1116,2040-1124

E-ISSN

2040-1124

DOI

10.1111/jdi.14267

How to access this item